Great Bay Bio Holdings Ltd. 

Potentially disruptive AI+ Bioproduction Application.

OWNER

Michael Chen (See Profile)

Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

British Virgin Islands


Be able to obtain the most productive monoclones in 4 hours, time saving up to 80%.

Labor cost saving up to 80%.

Obtain highest-yield cells from cell pool.

This information is confidential, do not share or copy.

Under evaluation at least till: 30th October

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar